Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

European glucose monitoring market set to double by 2016

This article was originally published in Clinica

Executive Summary

Europe’s continuous glucose monitoring (CGM) market will more than double by 2016, analysts Frost & Sullivan believe. This growth is in response primarily to the increasing demand for an easy-to-use and patient-friendly glucose-monitoring device. The segment will generate revenues totalling $52m in 2016, up from an estimated $23.5m in 2009, according to the report European Market for Continuous Glucose Monitoring, which covers the Benelux countries, France, Germany, Italy, Scandinavia, Spain and the United Kingdom.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095233

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel